Patent · US Active

3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death

US9862678B2 · kind B2 · utility

1Cited by

2References

9Claims

0Family size

Assignees

Inventors

Peter Vandenabeele · Sint-Amandsberg, BE
Tom Vanden Berghe · Haasdonk, BE
Koen Augustyns · Holsbeek, BE
Jurgen Joossens · Wilrijk, BE
Pieter Van Der Veken · Wilrijk, BE
Sam Hofmans · Willebroek, BE

Key dates

Filing date	Nov 16, 2015
Grant date	Jan 9, 2018
Priority date	—
Expiry date	Nov 16, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2603/74
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

This disclosure relates to a novel class of compounds having the structure of formula I as defined herein and pharmaceutical compositions comprising a compound of formula I or a pharmaceutically acceptable salt thereof. This disclosure also comprises methods of treating a subject by administering a therapeutically effective amount of a compound of formula I or a pharmaceutically acceptable salt thereof to the subject. These compounds are useful for the conditions disclosed herein. This disclosure further comprises methods for making the compounds of formula I and corresponding intermediates.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.